在PharmD非处方治疗课程中对同行,自我和教师客观结构化临床检查评估的比较
Riley D Bowers1, Carrie N Baker1, Kaitlyn K Becker1
1Campbell University College of Pharmacy & Health Sciences, PO Box 1090, Buies Creek, NC 27506, USA.
Currents in pharmacy teaching & learning
|August 1, 2024
概括
客观结构化临床检查 (OSCE) 中的同行和自我评估与高成绩药学学生的教师分数密切匹配,为低风险评估提供了可行的替代方案.
科学领域:
- 医疗保健教育卫生保健教育
- 药房课程 药房课程 药房课程
- 临床能力评估临床能力评估
背景情况:
- 客观结构化临床检查 (OSCE) 对于评估医疗保健学生的临床技能至关重要.
- 欧安组织的教师分级可能是资源密集的.
- 探索替代评估方法对于有效的教育至关重要.
研究的目的:
- 为了比较教师,同行和自我评估之间的OSCE总体得分.
- 评估在药学教育中使用同行和自我评估的可行性.
- 调查不同评价组的评价者之间的可靠性和反类型.
主要方法:
- 七十七名一年级药学博士的学生参加了.
- 学生被教师,同学和自我评估评估,使用标准化标签.
- 数据分析的重点是比较整体得分和评级者之间的可靠性.
主要成果:
- 自我和同行评估显示,彼此之间没有显著差异.
- 自我和同行评价的分数明显高于教师评价 (p < 0.001).
- 对于总体的字母等级,观察到强大的评级者间可靠性 (W分数 = 0.79),对于更高的等级,评级者同意度更高.
结论:
- 同行评价和自我评价可以作为欧安组织的教师评级的可比替代方案,特别是对于表现更高的学生.
- 评分的差异表明,这些方法最适合用于低风险评估和基本技能评估.
- 这项研究突出了药房计划中欧安组织评估的潜在效率.
相关概念视频
Nursing Evaluation
3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Drug Administration and Therapy Phases: Overview
426
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
426
Bioequivalence: Overview
957
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
957
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


